These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22204740)

  • 21. A novel series of potent and selective EP(4) receptor ligands: facile modulation of agonism and antagonism.
    Boyd MJ; Berthelette C; Chiasson JF; Clark P; Colucci J; Denis D; Han Y; Lévesque JF; Mathieu MC; Stocco R; Therien A; Rowland S; Wrona M; Xu D
    Bioorg Med Chem Lett; 2011 Jan; 21(1):484-7. PubMed ID: 21126875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of a novel, potent and orally active series of gamma-lactams as selective NK1 antagonists.
    Paliwal S; Reichard GA; Shah S; Wrobleski ML; Wang C; Stengone C; Tsui HC; Xiao D; Duffy RA; Lachowicz JE; Nomeir AA; Varty GB; Shih NY
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4168-71. PubMed ID: 18547807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved.
    Józefowski S; Bobek M; Marcinkiewicz J
    Int Immunopharmacol; 2003 Jun; 3(6):865-78. PubMed ID: 12781703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The identification of substituted benzothiophene derivatives as PGE(2) subtype 4 receptor antagonists: From acid to non-acid.
    Li L; Mathieu MC; Denis D; Therien AG; Wang Z
    Bioorg Med Chem Lett; 2011 Jan; 21(2):734-7. PubMed ID: 21208803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
    Franchini S; Prandi A; Baraldi A; Sorbi C; Tait A; Buccioni M; Marucci G; Cilia A; Pirona L; Fossa P; Cichero E; Brasili L
    Eur J Med Chem; 2010 Sep; 45(9):3740-51. PubMed ID: 20605276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bladder outlet obstruction induced expression of prostaglandin E2 receptor subtype EP4 in the rat bladder: a possible counteractive mechanism against detrusor overactivity.
    Beppu M; Araki I; Yoshiyama M; Du S; Kobayashi H; Zakoji H; Takeda M
    J Urol; 2011 Dec; 186(6):2463-9. PubMed ID: 22019172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of prostaglandin E2 in the synthesis of the pro-inflammatory cytokine interleukin-6 in primary sensory neurons: an in vivo and in vitro study.
    St-Jacques B; Ma W
    J Neurochem; 2011 Sep; 118(5):841-54. PubMed ID: 21371033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profile.
    Blanco MJ; Vetman T; Chandrasekhar S; Fisher MJ; Harvey A; Chambers M; Lin C; Mudra D; Oskins J; Wang XS; Yu XP; Warshawsky AM
    Bioorg Med Chem Lett; 2016 Feb; 26(3):931-935. PubMed ID: 26764191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.
    Duffy MM; Pindjakova J; Hanley SA; McCarthy C; Weidhofer GA; Sweeney EM; English K; Shaw G; Murphy JM; Barry FP; Mahon BP; Belton O; Ceredig R; Griffin MD
    Eur J Immunol; 2011 Oct; 41(10):2840-51. PubMed ID: 21710489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevention of colitis by E Prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration.
    Jiang GL; Nieves A; Im WB; Old DW; Dinh DT; Wheeler L
    J Pharmacol Exp Ther; 2007 Jan; 320(1):22-8. PubMed ID: 17008451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting therapeutics to bone by conjugation with bisphosphonates.
    Young RN; Grynpas MD
    Curr Opin Pharmacol; 2018 Jun; 40():87-94. PubMed ID: 29626715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous prostaglandin E2 inhibits aberrant overgrowth of rheumatoid synovial tissue and the development of osteoclast activity through EP4 receptor.
    Shibata-Nozaki T; Ito H; Mitomi H; Akaogi J; Komagata T; Kanaji T; Maruyama T; Mori T; Nomoto S; Ozaki S; Yamada H
    Arthritis Rheum; 2011 Sep; 63(9):2595-605. PubMed ID: 21898865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central PGE2 exhibits anxiolytic-like activity via EP1 and EP4 receptors in a manner dependent on serotonin 5-HT1A, dopamine D1 and GABAA receptors.
    Suzuki C; Miyamoto C; Furuyashiki T; Narumiya S; Ohinata K
    FEBS Lett; 2011 Jul; 585(14):2357-62. PubMed ID: 21693121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of novel pyrazolidinone analogs of PGE2 as EP2 and EP4 receptors agonists.
    Zhao Z; Araldi GL; Xiao Y; Reddy AP; Liao Y; Karra S; Brugger N; Fischer D; Palmer E
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6572-5. PubMed ID: 17931866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.
    Enz A; Feuerbach D; Frederiksen MU; Gentsch C; Hurth K; Müller W; Nozulak J; Roy BL
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1287-91. PubMed ID: 19208472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SmI2-mediated intermolecular coupling of γ-lactam N-α-radicals with activated alkenes: asymmetric synthesis of 11-hydroxylated analogues of the lead compounds CP-734432 and PF-04475270.
    Hu KZ; Ma J; Qiu S; Zheng X; Huang PQ
    J Org Chem; 2013 Mar; 78(5):1790-801. PubMed ID: 22853560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of a selective EP4-receptor agonist. Part 4: practical synthesis and biological evaluation of a novel highly selective EP4-receptor agonist.
    Maruyama T; Kuwabe SI; Kawanaka Y; Shiraishi T; Shinagawa Y; Sakata K; Seki A; Kishida Y; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Hashimoto S; Kawamura M; Kondo K; Toda M
    Bioorg Med Chem; 2002 Jul; 10(7):2103-10. PubMed ID: 11983506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of highly selective EP4 receptor agonists that stimulate new bone formation and restore bone mass in ovariectomized rats.
    Cameron KO; Lefker BA; Chu-Moyer MY; Crawford DT; Jardine PD; DeNinno SL; Gilbert S; Grasser WA; Ke H; Lu B; Owen TA; Paralkar VM; Qi H; Scott DO; Thompson DD; Tjoa CM; Zawistoski MP
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1799-802. PubMed ID: 16442794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
    Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
    J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.